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Whether renal dysfunction is an important factor in
postoperative risk assessment has been difficult to prove.
In an attempt to provide more compelling evidence, we
conducted a systematic review comparing the risk of death
and cardiac events in patients with and without chronic
kidney disease who underwent elective noncardiac surgery.
From electronic databases, web search engines, and
bibliographies, 31 cohort studies were selected, evaluating
postoperative outcomes in patients with chronic kidney
disease. These patients had higher risks of postoperative
death and cardiovascular events compared to those with
preserved renal function. The pooled incidence of
postoperative death was significantly less in those with
preserved renal function than in those patients with chronic
kidney disease. Meta-regression showed a graded
relationship between disease severity and postoperative
death. In adjusted analysis, chronic kidney disease had a
similar strength of association with postoperative death as
diabetes, stroke, and coronary disease. Our review identifies
chronic kidney disease as an independent risk factor for
postoperative death and cardiovascular events after elective,
noncardiac surgery.
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Worldwide, over 100 million elective noncardiac surgeries are
performed annually.1 There are many reasons to pursue
surgery: for example, total hip arthroplasty dramatically
improves quality of life,2 lower limb bypass surgery reduces
claudication and prevents the development of advanced
limb ischemia,3 and abdominal aortic aneurysm repair
improves long-term survival.4 Despite these benefits, non-
cardiac surgery is associated with risks of death and major
cardiovascular events. Based on national surgical data, which
include all adults undergoing any type of noncardiac surgery
that requires a length of stay X24 h, it has been concluded
that noncardiac surgery is associated with substantial hospital
mortality (1 out of 142 cases dies).5
Chronic kidney disease affects 5% of the population,6
encompassing all levels of renal impairment including
dialysis dependence. Chronic kidney disease in the non-
surgical setting is an established independent predictor
of mortality and cardiovascular events.7–9 However, there
is uncertainty regarding the prognostic significance of renal
dysfunction before surgery. Some risk indices consider renal
dysfunction as an important prognostic factor in post-
operative risk assessment,10–12 whereas others do not.13,14 If
chronic kidney disease is an independent risk factor for
postoperative death, this knowledge could direct patient and
physician decision-making on appropriateness of surgery and
guide postoperative patient care. We undertook a systematic
review and meta-analysis addressing the following question:
is chronic kidney disease an independent predictor of
mortality and cardiovascular events in patients undergoing
elective, noncardiac surgery?
RESULTS
Review flow
We screened 2160 citations and evaluated the eligibility of
each of the 159 retrieved full-text articles (Figure 1).
Study characteristics
Thirty-one studies from seven countries followed 153 885
patients of whom 125 930 had normal kidney function and
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27 955 had chronic kidney disease (Table 1). The methodo-
logical quality of each study is shown in Table 2. Of the
31 studies, 13 collected data prospectively11,12,15–23 whereas
18 used retrospective data from health records.24–40 Two
studies used variables such as age, sex, cardiovascular risk
factors, and surgical risk, to match patients with normal
kidney function to those with chronic kidney disease.27,33 All
31 studies had representative study samples and adequately
defined selection criteria and chronic kidney disease. Eight
studies reported loss to follow-up; in 6 studies, it waso10%.
Confounders that may influence the association between
chronic kidney disease and outcomes were not adequately
considered in 10 studies (Table 2). Mean age was 67 years
(range 52–73) for all patients and 70 years (range 5–76) for
those with chronic kidney disease. Seventy-six percent of
patients were men, and 73% were Caucasian. Eighty-one
percent of studies examined vascular procedures (23%
abdominal or thoracoabdominal aortic aneurysm repair,
19% lower extremity procedures, 23% carotid endarterect-
omy, and 16% combined vascular procedures). The remain-
ing 19% of surgeries were general procedures or all types of
noncardiac surgery combined. Sensitivity analyses excluding
studies conducted retrospectively or those with emergency
surgery or from the United States Veterans Administration
did not meaningfully change the results.
Definitions for preoperative chronic kidney disease varied,
with 21 studies using elevated serum creatinine and 7 studies
using reduced estimated glomerular filtration rate (GFR) or
creatinine clearance assessed by estimating equations based
on serum creatinine.41,42 Three studies defined chronic
kidney disease using dialysis dependence.
Postoperative mortality was defined as deaths after surgery
during the stay in the same hospital being admitted or
within 30 days after surgery. Most deaths were caused by
cardiovascular events, followed by sepsis. Cardiovascular
events were defined as any one of the following occurring
within 30 days or during the stay in the same hospital being
admitted: myocardial infarction, angina, congestive heart
failure, pulmonary edema, cardiac arrest, and arrhythmia.
Quantitative data synthesis
The chance-corrected agreement was very good between two
independent reviewers who evaluated study eligibility
(k¼ 0.79). There was no significant publication bias as
assessed by funnel plot graph and Egger’s test (P¼ 0.96).
Postoperative mortality in patients with chronic kidney
disease
Twenty-six studies described the unadjusted risk of post-
operative death in patients with chronic kidney
Studies excluded (n=128)b
 No control group (n=41)
 No useable data (n=37)
 No preoperative renal function (n=12) 
 No outcome of interest (n=12) 
 Review/meta-analysis (n=9) 
 Study population less than100 (n=5) 
 Confounders not addressedc (n=3)
 Renal type of surgery (n=2) 
 Greater than 25% emergent surgery (n=3) 
 Non-representative study population (n=2)
 Only included patients with acute kidney injury (n=1) 
 Same group of patients described in multiple articles (n=1) 
bStudies were excluded as the first criteria was met. 
cNo matching of key patient characteristics, lack of adjustment in data analysis.
Potentially relevant
citations screened for 
retrieval  (n=2160) 
Studies retrieved for 
evaluationa
(n=159) 
Studies included in 
systematic review 
(n=31)
Citations excluded (n=2004) 
aDiscrete cohorts within one article are defined as separate studies.
Figure 1 | Selection of studies. aDiscrete cohorts within one article are defined as separate studies. bStudies were excluded as the first criteria
was met. cNo matching of key patient characteristics, lack of adjustment in data analysis.
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Table 1 | Baseline characteristics of included studies
First author, year
of publication Country
No. of patients
with normal
kidney function
No. of patients
with reduced
kidney function
Mean Age
(s.d.) Male (%)
Definition of reduced
kidney functiona Type of surgery Postoperative outcome(s) studied
Azizzadeh, 2006 USA 150 184 73 (y) 85 GFRp60 ml/minb Endovascular repair of abdominal
aortic aneurysm
30-day mortality
Collins, 2001c USA 1467 801 68 (7) 100 Cr4106mmol/l Abdominal aortic aneurysm repair 30-day mortality
Huynh, 2005 USA 451 466 67 (y) 64 GFRo65 ml/minb Thoracoabdominal aneurysm repair 30-day mortality
Komori, 1997 Japan 273 50 69 (8) 84 Cr4177mmol/l Abdominal aortic aneurysm repair Postoperative mortality
Mehta, 2004 USA 108 92 72 (y) 83 CrX133mmol/l Endovascular repair of abdominal
aortic aneurysm
30-day mortality
Powell, 1997 USA 162 48 69 (3) 76 GFRo45 ml/minb Abdominal aortic aneurysm repair 30-day mortality
Vasquez, 2004 USA 130 83 65 (8) 88 Cr4130mmol/l Endovascular repair of abdominal
aortic aneurysm
30-day mortality, CVS sequelae
Harpavat, 1998 USA 173 14 68 (y) 63 Cr4159mmol/l Lower-extremity bypass 30-day mortality, CVS sequelae
Lantis, 2001 USA 481 97 68 (y) 54 Cr4106mmol/l Lower-extremity bypass 30-day mortality, CVS sequelae
Nicholas, 2000 USA 46 57 69 (10) — Dialysis dependent Lower-extremity bypass In-hospital mortality
O’Hare, 2003 USA 13 292 4925 — 99 GFRp60 ml/min per
1.73m2d
Lower-extremity bypass 30-day mortality, CVS sequelae
O’Hare, 2004 USA 11 051 5943 — 99 GFRp60 ml/min per
1.73m2d
Lower-extremity amputation 30-day mortality, CVS sequelae
Collins, 2001e USA 5225 2862 65 (8) 99 Cr4106mmol/l Lower-extremity amputation or
bypass
30-day mortality
Ascher, 2005 USA 443 166 73 (9) 57 CrX133mmol/l Carotid endarterectomy 30-day mortality
Ayerdi, 2001 USA 448 57 70 (8) 63 Cr4160mmol/l Carotid endarterectomy 30-day mortality, CVS sequelae
Debing, 2006 Belgium 909 102 68 (y) — Cr4133mmol/l Carotid endarterectomy 30-day mortality
Hamdan, 1999 USA 928 73 70 (y) 61 Cr4133mmol/l Carotid endarterectomy 30-day mortality, CVS sequelae
Reil, 2002 USA 330 68 71 (y) 68 Cr4177mmol/l Carotid endarterectomy 30-day mortality, CVS sequelae
Rigdon, 1997 USA 221 16 62 (y) 58 Cr4177mmol/l Carotid endarterectomy 30-day mortality, CVS sequelae
Stoner, 2006 USA 11 679 1943 69 (y) 95 Cr4177mmol/l Carotid endarterectomy 30-day mortality, CVS sequelae
Axelrod, 2004 USA 19 094 943 66 (y) 100 Dialysis dependent Aortic reconstruction, lower-
extremity bypass, amputation
30-day mortality
Gerrard, 2002 UK 1103 51 — — Cr4400mmol/l Arterial reconstruction 30-day mortality
Kertai, 2003 The
Netherlands
852 561 70 (10) — CrClo63 ml/minb Abdominal aortic aneurysm repair,
infrainguinal reconstruction
30-day mortality
Kertai, 2005f The
Netherlands
1460 77 68 (3) 75 Cr4177mmol/l Thoracoabdominal/abdominal
aneurysm repair, lower-extremity
bypass, carotid endarterectomy
30-day mortality
Kertai, 2005g The
Netherlands
719 54 68 (3) 77 Cr4177mmol/l Thoracoabdominal/abdominal
aneurysm repair, lower-extremity
bypass, carotid endarterectomy
30-day mortality
O’Brien, 2002 USA 42 822 6259 62 (y) 96 CrX133mmol/l All general surgery 30day mortality, CVS sequelae
Yeh, 2005 Taiwan 6182 58 52 (14) — Dialysis dependent Laparoscopic cholecystectomy Postoperative mortality
Browner, 1992 USA 370 104 — 100 CrClo50 ml/minb All elective, noncardiac surgery In-hospital mortality
Dehne, 2005 Germany 1649 1649 62 (15) 38 Cr4115mmol/l All noncardiac surgery In-hospital mortality
Lee, 1999f USA 2790 103 66 (10) 48 Cr4177mmol/l All elective, noncardiac surgery CVS sequelae
Lee, 1999g USA 1367 55 66 (10) Cr4177mmol/l All elective, noncardiac surgery CVS sequelae
CVS, cardiovascular.
Ellipses indicate data not reported in primary article.
CVS sequelae defined as any one or composite of arrhythmia, CHF, angina, cardiac arrest, pulmonary edema.
aTo convert serum creatinine value in units of mmol/l to mg/dl, divide value by 88.4.
bCalculated using the Cockroft–Gault formula.
cAbdominal aneurysm repair cohort.
dCalculated using the modification of diet in renal disease formula.
eLower-extremity bypass or amputation cohort.
fDerivation cohort.
gValidation cohort.
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Table 2 | Methodological quality of included studies
Study, year Cohort study design
Representative
sample
Selection criteria
defined
Loss to follow-up
reported
Loss to follow-up
o10%
Kidney dysfunction
defined
Outcome measure
defined
Confounders
addresseda
Azizzadeh, 2006 Prospective Yes Yes Yes Yes Yes Yes No
Collins, 2001b Retrospective Yes Yes No — Yes Yes Yes
Huynh, 2005 Prospective Yes Yes No — Yes Yes No
Komori, 1997 Retrospective Yes Yes No — Yes Yes No
Mehta, 2004 Retrospective Yes Yes No — Yes Yes Yes
Powell, 1997 Retrospective Yes Yes No — Yes Yes Yes
Vasquez, 2004 Prospective Yes Yes No — Yes Yes Yes
Harpavat, 1998 Retrospective Yes Yes Yes No Yes Yes No
Lantis, 2001 Retrospective Yes Yes Yes No Yes Yes No
Nicholas, 2000 Retrospective,
matched
Yes Yes No — Yes Yes No
O’Hare, 2003 Retrospective Yes Yes Yes Yes Yes Yes Yes
O’Hare, 2004 Retrospective Yes Yes Yes Yes Yes Yes Yes
Collins, 2001c Retrospective Yes Yes No — Yes Yes Yes
Ascher, 2005 Prospective Yes Yes No — Yes Yes Yes
Ayerdi, 2001 Retrospective Yes Yes No — Yes Yes no
Debing, 2006 Prospective Yes Yes No — Yes Yes Yes
Hamdan, 1999 Prospective Yes Yes No — Yes Yes No
Reil, 2002 Retrospective Yes Yes No — Yes Yes Yes
Rigdon, 1997 Retrospective Yes Yes No — Yes Yes Yes
Stoner, 2006 Retrospective Yes Yes No — Yes Yes No
Axelrod, 2004 Retrospective Yes Yes Yes Yes Yes Yes No
Gerrard, 2002 Prospective Yes Yes No — Yes Yes Yes
Kertai, 2003 Retrospective Yes Yes No — Yes Yes Yes
Kertai, 2005d Prospective Yes Yes No — Yes Yes Yes
Kertai, 2005e Prospective Yes Yes No — Yes Yes Yes
O’Brien, 2002 Retrospective Yes Yes Yes Yes Yes No Yes
Yeh, 2005 Prospective Yes Yes No — Yes No Yes
Browner, 1992 Prospective Yes Yes Yes Yes Yes No Yes
Dehne, 2005 Retrospective,
matched
Yes Yes No — Yes No Yes
Lee, 1999d Prospective Yes Yes No — Yes Yes Yes
Lee, 1999e Prospective Yes Yes No — Yes Yes Yes
Ellipses indicate data not reported.
aNo matching of key patient variables, lack of adjustment in data analysis, or relevant confounders were not considered or defined.
bAbdominal aneurysm repair cohort.
cLower-extremity bypass or amputation cohort.
dDerivation cohort.
eValidation cohort.
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disease compared with those with normal renal func-
tion11,15–22,25,26,28–40,43 (Figure 2). Studies were grouped
by type of surgery. Seven studies examined the risk of death
after open thoracoabdominal/abdominal aortic aneurysm
repair, a high-risk surgery. In total, 2863 patients had normal
kidney function and 1610 patients had chronic kidney
disease. The absolute incidence of postoperative mortality
in patients with normal kidney function ranged from 0 to
9.5% (pooled incidence of 3.2%) and in chronic kidney
disease patients it ranged from 2.0 to 22.5% (pooled
incidence of 9.2%) for all studies. The pooled absolute risk
increase of death in patients with chronic kidney disease
compared with those with normal kidney function was 4.7%
and ranged from 1.6 to 13% for all studies. The pooled
unadjusted odds ratio (OR) of death in patients with chronic
kidney disease compared to those with normal kidney
function was 2.8 (95% confidence interval (CI) 2.1–3.7).
There was no statistical heterogeneity for the ORs reported in
each of the studies (x2¼ 4.76; P¼ 0.58; I2¼ 0%).
Similar analyses were conducted for other types of
surgeries, including lower extremity vascular bypass or
amputation, carotid endarterectomy, general surgery, vascu-
lar surgery, and noncardiac surgery. Across all surgery types,
the association between chronic kidney disease and post-
operative death was similar to that observed for thoraco-
abdominal/abdominal aortic aneurysm repair. The pooled
absolute risk increase for postoperative mortality ranged
from 2.1 to 12.3%. The pooled unadjusted OR ranged from
1.9 to 5.6, and the lower bound of the 95% CI was greater
than 1.0 in 73% of the studies (Figure 2).
Twelve studies examined the risk of postoperative morta-
lity in patients with chronic kidney disease, adjusted for
Source
Definition of
chronic kidney
disease
Dialysis
(%)
Chronic kidney
disease
n/N (%)
Normal kidney
function
n/N (%)
Absolute risk
difference
% (95% CI) Odds ratio (95% CI)
Thoracoabdominal/abdominal aortic aneurysm
Collins (2001)a
Huynh (2005)
Azizzadeh (2006)
Komori (1997)
Vasquez (2004)
Powell (1997)
Mehta (2004)
Subtotal
Cr>106 µmol/l
Cr>133 µmol/l
Cr>159 µmol/l
Cr>177 µmol/l
Cr>133 µmol/l
Cr>133 µmol/l
Cr>115 µmol/l
Cr>177 µmol/l
Cr>177 µmol/l
Cr>400 µmol/l
Crcl<64 ml/min
CrCl<50 ml/min
Cr>133 µmol/l
Cr>133 µmol/l
Cr>160 µmol/l
Cr>177 µmol/l
Cr>177 µmol/l
Cr>106 µmol/l
Cr>106 µmol/l
Cr>177 µmol/l
Cr>130 µmol/l
GFR<60 ml/min
GFR<60 ml/min
GFR<60 ml/min per 1.73m2
GFR<60 ml/min per 1.73m2
GFR<45 ml/min
0
0
0
.. .,
†
. . .,
†
. . .,
†
. . .,
‡
. . .,
‡
. . .,
‡
. . .,
‡
. . .,
‡
. . .,
‡
. . .,
‡
. . .,
‡
. . .,
‡
45/788 (5.7)
82/365 (22.5)
5/184 (2.7)
1/50 (2.0)
5/83 (6.0)
4/48 (8.3)
6/92 (6.5)
148/1610 (9.2)
33/1467 (2.2)
50/529 (9.5)
0/194 (0.0)
1/273 (0.4)
2/130 (1.5)
1/162 (0.6)
5/108 (4.6)
92/2863 (3.2)
3.5 (1.7, 5.3)
13 (8.1, 17.9)
2.7 (0.02, 5.3)
1.6 (–2.3, 5.6)
4.5 (–1.1, 10)
7.7 (–0.01, 15.6)
1.9 (–4.5, 8.3)
4.7 (1.7, 7.6)
2.6 (1.7, 4.2)
2.8 (1.9, 4.1)
11.9 (0.7, 217.1)
5.6 (0.3, 90.2)
4.1 (0.8, 21.7)
14.6 (1.6, 134.3)
1.4 (0.4, 4.9)
2.8 (2.1, 3.7)
Test for heterogeneity for pooled OR: χ2 = 4.76, df = 6 (P=0.58), I2=0%
Test for heterogeneity for pooled OR: χ2 = 5.23, df = 4 (P=0.26), I2=23.5%
Test for heterogeneity for pooled OR: χ2 = 12.36, df = 6 (P=0.05), I2=51.5%
Test for heterogeneity for pooled OR: χ2 = 13.00, df = 6 (P=0.04), I2=53.9%
Lower Extremity Revascularization/ Amputation
O’Hare (2003)
O’Brien (2002)
O’Hare (2004)
Collins (2001)b
Lantis (2001)
Harpavat (1998)
Subtotal
Subtotal
Subtotal
0
0
0
0
0
217/4542 (4.8)
506/4833 (10.5)
141/2571 (5.5)
0/37 (0.0)
0/13 (0.0)
864/11 996 (7.2)
290/13 292 (2.2)
637/11 051 (5.8)
179/5225 (3.4)
2/481 (0.4)
7/173 (4.0)
1115/30 222 (3.7)
2.6 (1.9, 3.3)
4.7 (3.7, 5.7)
2.1 (1.1, 3.1)
–0.4 (–4.1, 3.3)
–4.1 (–14.2, 6.1)
2.6 (1, 4.1)
2.2 (1.9, 2.7)
1.9 (1.7, 2.2)
1.6 (1.3, 2.1)
2.6 (0.1, 54.2)
0.8 (0, 15.2)
1.9 (1.7, 2.2)
2.5 (1.9, 3.2)
4.1 (1.2, 13.5)
12.9 (0.8, 208)
30.2 (1.7, 549.4)
9.9 (2.4, 40.8)
1.6 (0.1, 39.8)
16.8 (3.1, 91.4)
5.6 (2.5, 12.4)
2.4 (1.5, 3.3)
2.9 (–0.9, 6.8)
1.3 (–1.4, 3.9)
3 (0.3, 5.7)
7.3 (–0.45, 14.9)
–0.3 (–2.4, 1.8)
17.4 (–1.8, 36.6)
2.1 (0.6, 3.6)
199/11 679 (1.7)
9/909 (1.0)
1/928 (0.1)
0/443 (0.0)
4/448 (0.9)
1/330 (0.3)
3/221 (1.4)
217/14 958 (1.5)
80/1943 (4.1)
4/102 (3.9)
1/73 (1.4)
5/166 (3.0)
4/49 (8.2)
0/68 (0.0)
3/16 (18.8)
97/2417 (4.0)
3
4.1
9.6
0
10.3
Carotid Endarterectomy
Stoner (2006)
Debing (2006)
Hamdan (1999)
Ascher (2005)
Ayerdi (2001)
Reil (2002)
Rigdon (1997)
Other: All types, General Surgery
Dehne (2005)
Kertai (2005)c
Gerrard (2002)
Kertai (2003)
Kertai (2005)d
Browner (1992)
0
825/6259 (13.2)
36/1649 (2.2)
25/77 (32.5)
9/51 (17.6)
32/291 (11.0)
15/54 (27.8)
15/103 (14.6)
957/8484 (11.3)
1327/42 822 (3.1)
15/1649 (0.9)
78/1460 (5.3)
43/1103 (3.9)
18/561 (3.2)
35/719 (4.9)
8/371 (2.2)
1524/48 685 (3.1)
10.1 (9.2, 10.9)
1.3 (0.4, 2.1)
27.1 (16.6, 37.7)
13.8 (3.2, 24.3)
7.8 (3.9, 11.7)
22.9 (10.9, 34.9)
12.4 (5.4, 19.4)
12.3 (5.9, 18.7)
4.7 (4.3, 5.2)
2.4 (1.3, 4.5)
8.5 (5, 14.5)
5.3 (2.4, 11.5)
3.7 (2.1, 6.8)
7.5 (3.8, 14.9)
7.7 (3.2, 18.8)
5.1 (3.8, 6.8)
0.1 1 10 50
Risk of death higher in patients Risk of death higher in patients
with normal kidney function with chronic kidney disease
Figure 2 | Risk of postoperative mortality in patients with chronic kidney disease. The size of each square is proportional to the
variability of the study estimate. Ellipses indicate not reported. n represents the number of patients who died and N represents the total
number of patients in the cohort. aAbdominal aneurysm repair cohort. bLower extremity surgery cohort. cDerivation cohort. dValidation
cohort. wStudy included dialysis patients but did not quantify the number. zStudy did not report whether dialysis patients were included.
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factors such as a history of diabetes,17,18,24,26,34–36,40 coronary
artery disease,11,18 congestive heart failure,11,24,34–36 hyper-
tension11,17,18,26 and older age.17,18,24,26,34–36,40 These results
were not pooled due to significant heterogeneity. The
adjusted OR of death in patients with chronic kidney disease
compared with those with normal kidney function was
consistently 41.4 (OR ranged from 1.4 to 6.8), and the lower
bounds of the 95% CIs were consistently 41.0 (95% CIs
ranged from 1.1 to 15.1) (Figure 3).
Six studies reported the adjusted OR between chronic
kidney disease and postoperative death, and the adjusted
odds for established risk factors such as diabetes, older age,
preexisting cerebrovascular disease, congestive heart failure,
or coronary artery disease. We compared the strength
of association for these various factors when the primary
study authors included them in the same multivariate model
(Table 3). In adjusted analysis from primary studies, the
strength of association between chronic kidney disease
and postoperative death was similar to the strength of the
association between other established risk factors and post-
operative death. Adjusted odds for established risk factors
ranged from 1.03 to 3.5, whereas adjusted ORs for chronic
kidney disease ranged from 1.5 to 5.2.
The relationship between severity of chronic kidney
disease and postoperative mortality was examined by meta-
regression analysis (Figure 4). Five studies reported the inci-
dence of postoperative mortality across a strata of patients
defined by their kidney function, and the data were
combined. A graded increase in postoperative mortality
was observed with declining GFR. Two of these five studies
also reported patient age across the same strata of kidney
function.36,37 There was no observed increase in age with
worsening renal function.
Postoperative cardiovascular events with chronic kidney
disease
Thirteen studies described the unadjusted risk of post-
operative cardiovascular events in patients with chronic
kidney disease compared with those with normal renal
function12,20,22,25,28,31,34–36,38–40 (Figure 5). Across all surgery
types, the incidence of postoperative cardiovascular events in
patients with normal kidney function ranged from 0.8 to
7.6% and in patients with chronic kidney disease it ranged
from 0 to 28.6%. The magnitude of the increased risk of
postoperative cardiovascular events associated with kidney
disease was similar to the excess risk of postoperative
mortality; in 10 of 13 studies, the lower bound of the 95%
CI of the OR in patients with chronic kidney disease
compared with those with normal kidney function was 41.0.
Four studies examined the risk of chronic kidney disease for
Source
Definition of
chronic kidney
disease Type of surgery
# with
chronic
kidney disease
# with
normal kidney
function Adjusted odds ratio (95% CI)
O’Brien (2002)
O’Hare (2003)
O’Hare (2004)
Stoner (2006)
Collins (2001)a
Axelrod (2004)
Collins (2001)b
Kertai (2005)c
Debing (2006)
Kertai (2005)d
Browner (1992)
Dehne (2005)
Odds ratios not pooled due to significant heterogeneity
Test for heterogeneity for pooled OR: χ2 = 78.09, df = 11 (P=0.001), I2=85.9%
Cr>133 µmol/l
Cr>177 µmol/l
Cr>106 µmol/l
Cr>106 µmol/l
Cr>177 µmol/l
Cr>133 µmol/l
Cr>177 µmol/l
Cr>115 µmol/l
CrCl<0.83 ml/min
GFR<60 ml/min per 1.73m2
GFR<60 ml/min per 1.73m2
Dialysis
Other: all types
Other: all types
All vascular
Carotid endarterectomy
All vascular
All vascular
Abdominal aortic aneurysm
Lower extremity
Lower extremity
Lower extremity
Carotid endarterectomy
Other: general surgery 5259
383
42 822
13 292
1943 11 679
11 051110
2862 5225
943 1904
801 1467
77 1460
102 909
54 719
104 370
50 50
0.5 1 5 18
Risk of death higher in patients
with normal kidney function
Risk of death higher in patients
with chronic kidney disease
2.6 (1.4, 4.9)
6.8 (2.8, 16)
6.7 (2.9, 15.1)
3.8 (1.1, 12.6)
5.2 (2.6, 10.2)
2 (1.2, 3.2)
2.3 (1.5, 3.5)
1.4 (1.1, 1.9)
3.4 (2.8, 4.1)
1.7 (1.2, 2.2)
4.4 (3, 6.5)
1.4 (1.2, 1.8)
Figure 3 | Adjusted risk of postoperative mortality in patients with chronic kidney disease. The size of each square is proportional to the
variability of the study estimate. aLower extremity surgery cohort. bAbdominal aneurysm repair cohort. cDerivation cohort. dValidation cohort.
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cardiovascular events, adjusting for other known prognostic
factors12,36,40 (Figure 6). In three of four studies, the adjusted
OR in patients with chronic kidney disease compared with
those with normal kidney function was 41.4, and among
these studies the lower bound of the 95% CI of the OR was
greater than 1.1 (range 1.2–2.0).
Table 3 | Multivariate ORs for postoperative mortality of established factors compared with chronic kidney disease
Type of surgery
Abdominal aortic
aneurysm
Lower-extremity
bypass/amputation
All vascular
surgery
Carotid
endarterectomy
Source Collins, 2001a Collins, 2001b Kertai, 2005c Kertai, 2005d Axelrod, 2004 Debing, 2006
Definition of chronic kidney disease Cr4106mmol/l Cr4106mmol/l Cr4177mmol/l Cr4177mmol/l Dialysis dependent Cr4133mmol/l
Multivariate model to predict postoperative mortality, ORs (95% CI)
Established prognostic factors
History of TIA/CVA 2.4 (1.2, 4.9) NS 2.7 (1.5, 4.7) 6.5 (2.8, 15) 6.3 (3.4, 11.4) NS
Diabetes mellitus NS 1.4 (1.1, 1.9) NS NS NS 3.0 (0.98, 9.0)
Age (per year) NS 1.03 (1.02, 1.05) — — 1.04 (1.02, 1.05) NS
Known CAD — — 3.5 (2.1, 6.0) 2.3 (1.1, 4.7) — NS
History of CHF — — 4.0 (1.9, 7.7) 3.5 (1.5, 8.6) 1.6 (1.1, 2.3) —
Chronic kidney disease 2.0 (1.2, 3.2) 1.5 (1.1, 1.9) 5.2 (2.6, 10.2) 2.4 (1.1, 5.1) 2.3 (1.5, 3.5) 3.8 (1.1, 12.6)
Other factors included in multivariate model
Albumin | | — — | —
COPD | | | | — |
ASA stage | | — — — —
Hypertension | | | | — |
DNR status | | — — — —
Impaired sensorium | | — — — —
Risk of Surgery — — — — | —
Coagulopathy — — — — | —
Hyperlipidemia — — — — — |
Ethnicity | | — — — —
Postoperative renal failure — — — — | —
Type of surgery — — | | — —
Medications — — | | — —
Smoking — — — — | |
Significant weight loss — — — — | —
Gender — — — — — |
Postoperative transfusion — — — — | —
ASA, American Society of Anesthesiology; CAD, coronary artery disease; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular
event; DNR, do not resuscitate; TIA, transient ischemic attack.
Ellipses indicate that the factor was not included in the multivariate model.
aAbdominal aneurysm repair cohort.
bLower-extremity surgery cohort.
cDerivation cohort.
dValidation cohort.
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Figure 4 | GFR and postoperative mortality. The area of each circle is proportional to the number of patients in GFR strata for each study. Best
fit lines with 95% CIs are from meta-regression (see the Materials and Methods section).
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Postoperative outcomes in patients receiving dialysis
The unadjusted risk of postoperative death and cardio-
vascular events in patients receiving dialysis was described in
nine studies23,25,26,28,31,33,35,36 (Figure 7a and b). Although
the amount of data was limited, patients receiving dialysis
were at highest risk of postoperative complications. For
example, the pooled risk of postoperative mortality due to
lower extremity revascularization or amputation in patients
with kidney disease not receiving dialysis compared with
those with normal renal function was 1.9 (Figure 2; six
studies, 95% CI 1.8–2.2). In comparison, the pooled risk of
postoperative mortality due to lower extremity bypass or
amputation in patients receiving dialysis compared with
those with normal renal function was 5.1 (95% CI 2.5–10.4,
based on six studies of 2451 patients receiving dialysis and
30 268 patients with normal renal function).26,28,31,33,35,36 The
precision of these pooled results should be interpreted
judiciously (x2¼ 11.32; P¼ 0.01; I2¼ 73.5%).
DISCUSSION
Across various types of noncardiac surgery, patients
with chronic kidney disease had two- to fivefold higher
risks of postoperative death and cardiovascular events than
those with normal kidney function. This increased risk
was substantial when expressed in absolute terms. For
example, after abdominal aortic aneurysm repair, the pooled
incidence of postoperative mortality was 3.2% in patients
with normal renal function and 9.2% in patients with chronic
kidney disease (pooled absolute risk increase of 4.7%).
A graded relationship existed between the severity of pre-
operative renal impairment and the incidence of post-
operative adverse events, independent of age as a confound-
Source
Definition of
chronic kidney
disease
Dialysis
(%)
Chronic kidney
disease
n/N (%)
Normal kidney
function
n/N (%)
Absolute risk
difference
(%) Odds ratio (95% CI)
Lower extremity revascularization/amputation
O’Hare (2003)
O’Brien (2002)
O’Hare (2004)
Lantis (2001)
Harpavat (1998)
Subtotal
GFR<60 ml/min per 1.73m2
GFR<60 ml/min per 1.73m2
Cr>106 µmol/l
Cr>159 µmol/l
Cr>177 µmol/l
Cr>133 µmol/l
Cr>160 µmol/l
Cr>177 µmol/l
Cr>177 µmol/l
0
0
0
0
244/4542 (5.4)
238/4833 (4.9)
2/37 (5.4)
0/14 (0.0)
484/9426 (5.1)
329/13 292 (2.5)
291/11 051 (2.6)
4/481 (0.8)
2/173 (1.2)
626/24 997 (2.5)
2.9 (2.2, 3.6)
2.3 (1.6, 3)
4.6 (–2.8, 11.9)
–1.2 (–10.4, 8.1)
2.6 (2.1, 3.1)
2.2 (1.9, 2.6)
1.9 (1.6, 2.3)
6.8 (1.2, 38.5)
2.4 (0.1, 51.6)
2.1 (1.8, 2.4)
1.9 (1.3, 2.8)
4.2 (1.5, 11.8)
7.1 (3.4, 14.9)
5.1 (1.2, 20.9)
1.9 (0.1, 38.2)
0.9 (0.3, 1.5)
5.1 (–0.7, 10.1)
23.2 (10.4, 36)
4.7 (–1.1, 10.4)
–1.4 (–9.6, 6.8)
117/11 679 (1.0)
16/928 (1.7)
24/448 (5.4)
4/330 (1.2)
3/221 (1.4)
37/1943 (1.9)
5/73 (6.9)
14/49 (28.6)
4/68 (5.9)
0/16 (0.0)
3
4.1
0
10.3
.. .,
‡
. . .,
‡
. . .,
‡
. . .,
‡
Test for heterogeneity for pooled OR: χ2 = 3.38, df = 3 (P=0.34), I2=11.2%
Test for heterogeneity for pooled OR: χ2 = 11.26, df = 4 (P=0.02), I2=64.5%
Test for heterogeneity for pooled OR: χ2 = 9.63, df = 3 (P=0.02), I2=68.9%
Carotid endarterectomy
Stoner (2006)
Hamdan (1999)
Ayerdi (2001)
Reil (2002)
Rigdon (1997)
Odds ratios not pooled due to significant heterogeneity
Odds ratios not pooled due to significant heterogeneity
Other: all types, general surgery
Lee (1999)a
Lee (1999)b
Vasquez (2004)
Cr>133 µmol/l
Cr>177 µmol/l
Cr>177 µmol/l
Cr>130 µmol/l 0
183/6259 (2.9)
9/103 (8.7)
3/55 (5.5)
5/83 (6.0)
343/42 822 (0.8)
46/2790 (1.6)
33/1367 (2.4)
10/130 (7.6)
2.1 (1.7, 2.6)
7.1 (1.6, 12.6)
3 (–3, 9.1)
–1.7 (–8.5, 5.2)
0.1 1 10 55
3.7 (3.1, 4.5)
5.7 (2.7, 12)
2.3 (0.7, 7.9)
0.8 (0.3, 2.3)
Risk of sequelae higher in patients
with normal kidney function
Risk of sequelae higher in patients
with chronic kidney disease
Figure 5 | Risk of postoperative cardiovascular events in patients with chronic kidney disease. Cardiovascular sequelae defined as
any one or composite of arrhythmia, CHF, angina, cardiac arrest, pulmonary edema. The size of each square is proportional to the v
ariability of the study estimate. Ellipses indicate not reported. n represents the number of patients who died and N represents the total
number of patients in the cohort. aDerivation cohort. bValidation cohort. zStudy did not report whether dialysis patients were included.
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ing factor. Patients receiving dialysis were at highest risk of
such events.
Patients with chronic kidney disease often have multiple
risk factors for adverse postoperative outcomes; some may
suspect that the presence of chronic kidney disease per se does
not appreciably increase postoperative risk. However, after
adjustment for established prognostic factors in multivariable
models, chronic kidney disease remained an independent risk
factor for postoperative mortality. The strength of the
association was similar to, or greater than, that associated
with other established risk factors,11,17,18,24,26 including
diabetes and known coronary disease. These results highlight
the potential utility of impaired kidney function as an easily
assessed marker of increased postoperative risk.
Strengths and limitations of this review
We conducted and reported this review in accordance with
published guidelines.44,45 As mortality rates in the control
groups are concordant with published data,46–48 and we
studied a large number of patients undergoing a wide range
of elective procedures, our results apply broadly to clinical
care. The results are unlikely to be biased due to selective
publication, and we justified our clinical and statistical
reasons for pooling some results to provide a more precise
estimate of the true effect. These results extend the findings of
a literature review conducted by Hallin et al.49 but contradict
another review conducted by Bown et al.50 Bown et al.
concluded that chronic kidney disease was not an indepen-
dent risk factor for postoperative mortality in patients
undergoing elective abdominal aortic aneurysm repair. That
review did not adhere to accepted criteria for review
reporting (1 out of 8 criteria),51 and during our study
selection, we excluded 443,52–54 of 7 studies included in Bown
et al.’s review for inadequate methodological quality. We
argue that our results describe the true relation between
chronic kidney disease and postoperative outcomes. None-
theless, despite careful examination of the data in this meta-
analysis of observational studies, it remains possible that
residual confounding and selection bias distorted the
results.55 There are examples where statistically combining
data from observational studies produced very precise, but
spurious, results.56
As with all systematic reviews, the strength of our
conclusions is influenced by the quality of primary studies.
We assessed the methodological quality of these studies using
accepted criteria.57 In roughly half of the studies, data were
collected retrospectively using existing health records. Only 8
studies reported whether patients were lost to follow-up, and
10 studies did not adequately adjust for relevant confounding
factors. However, in all studies that presented adjusted
mortality ORs, the lower bound of the CI remained above 1,
thus supporting a reliable result. We assumed that the
primary articles studied patients with defined chronic kidney
disease58 and not acute kidney injury. Primary articles used
several definitions for chronic kidney disease, complicating
the clinical application of these results. However, the effect
was observed across all thresholds of disease definition.
Misclassification of acute kidney injury as chronic kidney
disease may have influenced our estimates of postoperative
risk. Because relevant data were fairly complete, we did
not contact authors to obtain missing data from the
primary studies. We did not clarify the proportion of
cardiovascular events due to myocardial infarction or cardiac
arrest, which confer greater morbidity than outcomes
of angina and congestive heart failure described in some
studies.12,20,22,25,31,39
Source
Definition of
chronic kidney
disease Type of surgery
# with
chronic kidney
disease
# with
normal kidney
function Adjusted odds ratio (95% CI)
Stoner (2006)
O’Hare (2003)
Lee (1999)a
Lee (1999)b
Cr>177 µmol/l
Cr>177 µmol/l
Cr>177 µmol/l
GFR<60 ml/min per 1.73m2
Carotid endarterectomy
Lower extremity
Other: all types
Other: all types
1943
383
103
55
11 679
13 292
2790
1367
1.5 (1.2, 1.8)
3.5 (2, 6)
3 (1.4, 6.8)
0.9 (0.2, 3.3)
0.1 1 8
Risk of sequelae higher in patientsRisk of sequelae higher in patients
with chronic kidney diseasewith normal kidney function
Odds ratios not pooled due to significant heterogeneity
Test for heterogeneity for pooled OR: χ2 = 11.32, df = 3 (P=0.01), I2=73.5%
Figure 6 | Adjusted risk of cardiovascular sequelae in patients with chronic kidney disease. The size of each square is proportional to the
variability of the study estimate. aDerivation cohort. bValidation cohort.
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Informed consent, surgical decision-making, and preopera-
tive risk indices
Physicians can use our results, with knowledge of surgical
outcomes from their institution, including surgical expertise,
to guide decision-making around the appropriateness and
timing of elective surgery. For example, current guidelines for
management of abdominal aortic aneurysm recommend
elective repair when aneurysm size reaches 5.0–5.5 cm,4,59–61
based on a comparison of surgical risk with the likelihood of
spontaneous rupture with increasing aneurysm size. In this
review, primary studies that reported aneurysm size at the
time of surgery adhered to these guidelines.22,32 A recent
study by Lederle et al.60 compared mortality in early elective
surgery to surveillance in patients with abdominal aortic
aneuryms and reported a 30-day postoperative mortality rate
of 2.7% in the early elective surgery group (that is, patients
with aneurysms of 4.0–5.4 cm). A similar study was
conducted by the UK Small Aneurysms group.4 In patients
with aneurysms of 4.9–5.5 cm, this study reported a 9.5%
annual incidence of mortality from spontaneous rupture in
the surveillance group, compared to 7.4% in the post-
operative group. Our review showed that chronic kidney
disease patients had an absolute postoperative mortality rate
of 9.2%. Thus, if rates of spontaneous rupture are similar in
patients with and without chronic kidney disease, it may be
prudent to wait until the aneurysm is of larger diameter in
the former group before considering elective surgery.
Physicians can use the absolute rates and ORs presented in
this study during discussions with patients, as full disclosure
of the potential risk of elective surgery is required for patients
to provide informed consent. However, a risk analysis of the
conservative versus elective surgical management of chronic
kidney disease patients is necessary before clinical imple-
mentation of these results. Knowledge of expected adverse
Source Type of surgery
Dialysis
n/N (%)
Normal renal
function, n/N (%)
Absolute risk
difference (%) Odds ratio (95% CI)
O’Hare (2003)
O’Hare (2004)
O’Hare (2003)
O’Hare (2004)
Collins (2001)a
Lantis (2001)
Harpavat (1998)
Nicholas (2000)
Lower extremity bypass
Lower extremity bypass
Lower extremity bypass
Lower extremity bypass
Lower extremity bypass
Lower extremity amputation
40/383 (10.4)
175/1110 (15.8)
51/291 (17.5)
1/60 (1.7)
1/10 (10.0)
11/57 (19.3)
290/13 292 (2.2)
637/11 051 (5.8)
79/5225 (1.5)
2/481 (0.4)
7/173 (4.0)
3/46 (6.5)
8.3 (5.2, 11.3)
10 (7.8, 12.2)
16 (11.6, 20.4)
1.3 (–2, 4.5)
6 (–23.9, 24.8)
12.8 (0.3, 25.3)
5.2 (3.7, 7.4)
3.1 (2.6, 3.7)
13.8 (9.5, 20.1)
4.1 (0.4, 45.5)
2.6 (0.3, 23.8)
3.4 (0.9, 13.1)
501010.05
Risk of death higher in
patients on dialysis
Risk of death higher in patients
with normal kidney function
Odds ratios not pooled due to significant heterogenetiy
Test for heterogeneity for pooled OR: χ2 = 53.47, df = 5 (P<0.001), I2=90.6%
Test for heterogeneity: χ2 = 1.29, df = 3 (P=0.73), I2=0%
a
b
Source
Lantis (2001)
Harpavat (1998)
Pooled
Type of surgery
Dialysis
n/N (%)
Normal renal
function, n/N (%)
Absolute risk
difference (%) Odds ratio (95% CI)
Lower extremity bypass
Lower extremity bypass
Lower extremity bypass
Lower extremity amputation
26/383 (6.8)
76/1110 (6.8)
3/60 (5.0)
1/20 (5.0)
106/1573 (6.8)
329/13 292 (2.5)
291/11 051 (2.6)
4/481 (0.8)
2/173 (1.2)
626/24 997 (2.5)
4.3 (1.8, 6.9)
4.2 (2.7, 5.7)
4.2 (1.4, 9.7)
3.8 (–5.8, 13.5)
2.9 (1.9, 4.3)
2.7 (2.1, 3.5)
6.3 (1.4, 28.8)
4.5 (0.4, 52)
2.8 (2.3, 3.5)
551010.3
Risk of sequelae higher inRisk of sequelae higher in patients
patients on dialysiswith normal kidney function
Figure 7 | Postoperative risks in dialysis patients. (a) Risk of postoperative mortality in patients receiving dialysis. (b) Risk of postoperative
cardiovascular sequelae in patients receiving dialysis. The size of each square is proportional to the variability of the study estimate.
aLower extremity surgery cohort. n represents the number of patients who died and N represents the total number of patients in the cohort.
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risks could also guide the choice of surgical technique
and potentially influence decisions about the need for, and
duration of, intensive monitoring during the postoperative
period.
We found a graded relationship between severity of kidney
dysfunction and the incidence of postoperative mortality.
Unlike other comorbid conditions such as diabetes, physi-
cians can readily assess the severity of chronic kidney disease
on a numerical scale. Use of information on severity
of chronic kidney disease may permit refined assessment of
postoperative risk than provided by dichotomous informa-
tion on the presence or absence of comorbid conditions.
Some current guidelines13,62,63 classify a serum creatinine of
177 mmol l1 (2.0 mg dl1) or greater as an intermediate, but
not major, risk factor for postoperative death or cardiovas-
cular complications. We recommend further studies to
prospectively evaluate this graded relationship between stage
of chronic kidney disease and postoperative mortality. Future
revisions of risk indices could consider classifying earlier
stages of chronic kidney disease (that is, stages 1–2) as an
intermediate risk factor, and the presence of advanced kidney
disease as a major risk factor for adverse postoperative
outcomes.
Conclusions and future research
This review has clarified the importance of chronic kidney
disease as an independent risk factor for postoperative
mortality and cardiovascular events. The risk associated with
chronic kidney disease was similar to or greater than that
associated with established prognostic factors, was consistent
across multiple surgery types, and increased with severity of
renal dysfunction. To facilitate clinical decision-making,
prospective cohort studies are needed to compare outcomes
of elective surgery with continued conservative medical
management in patients with chronic kidney disease. Testing
interventions to reduce mortality in this patient population
remains a priority.64
MATERIALS AND METHODS
This review was conducted and reported in accordance with
published guidelines.44,45
Searching
We searched MEDLINE, EMBASE, CINAHL, BIOSIS, ISI Science
Citation Index, SCOPUS databases, Cochrane Library, and the Web
using Elsevier’s Scirus and Google Scholar, from the start date of
each source to September 2006. An experienced information
specialist developed search strategies using sensitive terms for
identifying causation and prognostic studies of postoperative risk.
We pilot-tested and modified the search strategies to ensure they
identified eligible articles. The final strategies included the terms
surgery, postoperative, preoperative, intraoperative, perioperative,
elective surgery, chronic kidney disease, CKD, chronic renal failure,
chronic renal insufficiency, glomerular filtration rate, end-stage
renal disease, ESRD, chronic hemodialysis, dialysis, hemodialysis,
and peritoneal dialysis. Identified terms were modified to corres-
pond to the tree structure and descriptors of different databases
(complete strategies available from authors on request). We
also compiled citations from information provided by content
experts, citation tracking in SCOPUS, and the ISI Science Citation
Index, using related articles features in PubMed, OVID, Elsevier’s
Scirus and Google Scholar, and reference lists of previous
reviews49,50,65–68 and all eligible studies.11,12,15–40 All citations were
downloaded into reference manager (version 10.0). Two reviewers
independently screened each citation and retrieved the full-text
article if they considered the citation relevant. For all English-
language publications, two reviewers independently evaluated the
eligibility of each retrieved full-text article, and disagreements
were resolved by consensus. Using a translator, one reviewer
evaluated the eligibility of all foreign-language full-text articles.
When data from the same group of patients were described in
multiple publications,30,69 we reviewed all publications and cited
the most representative one.
Selection
We included cohort studies that compared the risk of death and
cardiovascular events after elective noncardiac surgery in patients
with and without chronic kidney disease. We accepted one measure
of kidney impairment as chronic kidney disease unless the authors
stated an acute, transient kidney injury. Some studies did not report
outcomes for patients who underwent elective surgery separately
from those who had urgent surgery. When not reported separately,
we included studies where the proportion of urgent or emergent
surgeries was o15%. We excluded surgeries that involved the
kidney, such as renal transplant and renal artery bypass, because
these procedures are frequently associated with transient rather than
chronic kidney impairment. We excluded studies that followed less
than 100 patients, did not include a control group with normal
kidney function, or did not describe outcomes of postoperative
death or cardiovascular events. Studies published in any language
were eligible for review.70
Data extraction and validity assessment
Two reviewers independently extracted data from included studies
on methods, setting, type of surgery, patient characteristics,
definition of chronic kidney disease, and outcomes, and resolved
disagreements by consensus. Using recommended validity criteria,
one reviewer assessed the methodological quality of each study.57
When a study described results for discrete cohorts, we considered
each cohort as a separate study.
Chronic kidney disease was defined using a variety of measures:
estimated GFR, creatinine clearance, or serum creatinine. As
creatinine clearance is commonly used as an estimate for GFR,58
we use these concepts interchangeably. For studies included in
meta-regression analysis that only reported serum creatinine, we
converted the mean serum creatinine value to an equivalent
estimated GFR using cut-off points previously validated against
inulin clearance.71 When possible, we collected data on dialysis
patients separately. When outcomes were reported for more
than two different categories of renal function, we extracted data
for each stratum. For meta-regression analysis, when two categories
of kidney function were reported, we combined study results to
compare patients with normal kidney function to those with chronic
kidney disease in a dichotomous fashion, using the first cut-off value
of renal impairment defined by each study. Outcomes of interest
were either mortality or cardiovascular events occurring during
the same hospital admission or within 30 days after surgery. For all
relevant outcomes, we extracted the number of events, unadjusted
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association between chronic kidney disease and postoperative
mortality or cardiovascular events, and associations adjusted for
other prognostic factors.
Quantitative data synthesis
Reviewer agreement on study eligibility was quantified using the
kappa (k) statistic. Publication bias was assessed by funnel plot and
Egger’s test for funnel plot asymmetry.72 For this study-level meta-
analysis, the Q statistic was used to determine whether between-
study heterogeneity was present (Po0.1 was considered statistically
significant). The I2 statistic was used to quantify the magnitude
of heterogeneity. An I2 value represents the percentage of total
variation across studies that is due to heterogeneity rather than
chance, with values of 0–30, 31–50, and 450% representing mild,
moderate, and notable heterogeneity, respectively.73 When calculat-
ing the OR, if no events occurred in one of the groups, 0.5 was
added to each cell in the two-by-two table. Results for each surgical
subtype were mathematically pooled using techniques that
accounted for within-study and between-study heterogeneity
(random-effects method).74,75 The absolute risk difference between
those with and without chronic kidney disease was calculated by
subtracting the absolute risk of postoperative outcome in each
group, with results pooled for all studies using the random effects
method. To estimate average event rates, results for each group were
pooled.76 Data from studies that presented results for multiple strata
of patients defined by their chronic kidney disease (that is, GFR
30–59 and 15–29 ml min1) were included in an additional meta-
regression analysis examining the graded relationship between
severity of chronic kidney disease and mortality. In these analyses,
the level of renal dysfunction in each subgroup was categorized
by substituting the midpoint of the range for interval data and
adding or subtracting 15 ml min1 from bounded data.8 Each study
contributed multiple estimates of mortality in this analysis. We used
a random intercept logistic regression model77 to control for within-
study correlation, with mortality as the dependent variable and
GFR as the independent variable. The 95% CI for the best-fit line
was calculated using the parameter estimates and the estimated
covariance structure from the fitted model. Statistical analyses were
performed with SAS version 9.1, SPSS version 14.0, R version 2.0.1,
and Review Manager Version 4.2 for Windows.
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